Moore & Van Allen is raising money in support of the Pancreatic Cancer Action Network by participating in PurpleStride.
Just this year, pancreatic cancer has surpassed breast cancer to be the second most lethal cancer in the U.S. It is estimated that more than 53,000 people will be diagnosed with pancreatic cancer in the United States this year and approximately 72 percent of patients will die in the first year of diagnosis. Despite this fact, pancreatic cancer only receives 2% of the federal funding from the National Cancer Institute.
By making a donation to our team, you are supporting efforts to double survival for this deadly disease by 2020.
Please make a donation today and help us reach our fundraising goal!